Filing Details
- Accession Number:
- 0001610717-24-000457
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-08-27 17:58:04
- Reporting Period:
- 2024-08-27
- Accepted Time:
- 2024-08-27 17:58:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1885522 | Neumora Therapeutics Inc. | NMRA | Biological Products, (No Disgnostic Substances) (2836) | 844367680 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1992595 | Joshua Pinto | C/O Neumora Therapeutics, Inc. 490 Arsenal Way, Suite 200 Watertown MA 02472 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-08-27 | 15,693 | $11.39 | 138,965 | No | 4 | S | Indirect | See footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | See footnote |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 85,000 | Direct |
Footnotes
- The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on April 18, 2024 and subsequently amended on May 22, 2024.
- This transaction was executed in multiple trades at prices ranging from $11.1572 to $11.58, inclusive. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Shares held by Maple DE Holdings LLC.
Billionaire Hedge Funds
